Healthcare
Thursday, September 1, 2016
BRIEF-Cellect Biotechnology reports Q2 loss per share $0.01
* Cellect Biotechnology Ltd provides corporate update and
reports second quarter 2016 financial results
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment